Monday, December 18, 2006

How much are we paying these guys?
The FDA and two drug makers issued a warning for Rituxan, a drug commonly used to treat cancer and rheumatoid arthritis, after two patients taking the drug died. (WSJ)

Brilliant.

No comments: